CN101966322A - Traditional Chinese medicinal composition for treating ovarian cyst and preparation method thereof - Google Patents
Traditional Chinese medicinal composition for treating ovarian cyst and preparation method thereof Download PDFInfo
- Publication number
- CN101966322A CN101966322A CN2010102250802A CN201010225080A CN101966322A CN 101966322 A CN101966322 A CN 101966322A CN 2010102250802 A CN2010102250802 A CN 2010102250802A CN 201010225080 A CN201010225080 A CN 201010225080A CN 101966322 A CN101966322 A CN 101966322A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- chinese medicine
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 52
- 208000025661 ovarian cyst Diseases 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 239000003814 drug Substances 0.000 claims abstract description 57
- 241000660877 Coridius Species 0.000 claims abstract description 9
- 229940079593 drug Drugs 0.000 claims abstract description 6
- 239000000843 powder Substances 0.000 claims description 31
- 241000628997 Flos Species 0.000 claims description 20
- 210000000582 semen Anatomy 0.000 claims description 20
- 239000002775 capsule Substances 0.000 claims description 9
- 241000717739 Boswellia sacra Species 0.000 claims description 8
- 241001649190 Campsis Species 0.000 claims description 8
- 241001489978 Eupolyphaga Species 0.000 claims description 8
- 239000004863 Frankincense Substances 0.000 claims description 8
- 241000237903 Hirudo Species 0.000 claims description 8
- 241000283956 Manis Species 0.000 claims description 8
- 241001057584 Myrrha Species 0.000 claims description 8
- 240000000920 Typhonium flagelliforme Species 0.000 claims description 8
- 239000000571 coke Substances 0.000 claims description 8
- 239000009286 sanguis draxonis Substances 0.000 claims description 8
- 239000008187 granular material Substances 0.000 claims description 7
- 239000006187 pill Substances 0.000 claims description 7
- 241000726094 Aristolochia Species 0.000 claims description 6
- 235000014375 Curcuma Nutrition 0.000 claims description 6
- 241000545442 Radix Species 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 5
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 4
- 238000009472 formulation Methods 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 241000555682 Forsythia x intermedia Species 0.000 claims description 2
- 241000245240 Lonicera Species 0.000 claims description 2
- 241000612166 Lysimachia Species 0.000 claims description 2
- 241000753128 Periploca <moth> Species 0.000 claims description 2
- 241000405217 Viola <butterfly> Species 0.000 claims description 2
- 239000010135 fructus aurantii immaturus Substances 0.000 claims description 2
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 2
- 244000164439 Curcuma angustifolia Species 0.000 claims 1
- 206010011732 Cyst Diseases 0.000 abstract description 15
- 208000031513 cyst Diseases 0.000 abstract description 15
- 210000001015 abdomen Anatomy 0.000 abstract description 12
- 208000024891 symptom Diseases 0.000 abstract description 12
- 210000004291 uterus Anatomy 0.000 abstract description 12
- 239000002994 raw material Substances 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 9
- 230000005906 menstruation Effects 0.000 abstract description 8
- 230000002159 abnormal effect Effects 0.000 abstract description 3
- 206010010774 Constipation Diseases 0.000 abstract description 2
- 230000008901 benefit Effects 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract description 2
- 230000027939 micturition Effects 0.000 abstract description 2
- 210000000664 rectum Anatomy 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 206010061692 Benign muscle neoplasm Diseases 0.000 abstract 3
- 201000004458 Myoma Diseases 0.000 abstract 3
- 208000004998 Abdominal Pain Diseases 0.000 abstract 1
- 241000427159 Achyranthes Species 0.000 abstract 1
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000271309 Aquilaria crassna Species 0.000 abstract 1
- 241001546929 Campsis grandiflora Species 0.000 abstract 1
- 244000192528 Chrysanthemum parthenium Species 0.000 abstract 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 abstract 1
- 244000183685 Citrus aurantium Species 0.000 abstract 1
- 235000007716 Citrus aurantium Nutrition 0.000 abstract 1
- 240000009138 Curcuma zedoaria Species 0.000 abstract 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 abstract 1
- 244000075634 Cyperus rotundus Species 0.000 abstract 1
- 235000016854 Cyperus rotundus Nutrition 0.000 abstract 1
- 241000545744 Hirudinea Species 0.000 abstract 1
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 240000000233 Melia azedarach Species 0.000 abstract 1
- 208000021891 Micturition disease Diseases 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 241000283966 Pholidota <mammal> Species 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 241000913745 Spatholobus Species 0.000 abstract 1
- 241001521901 Tribulus lanuginosus Species 0.000 abstract 1
- 240000004824 Trimezia steyermarkii Species 0.000 abstract 1
- 208000028938 Urination disease Diseases 0.000 abstract 1
- 244000178320 Vaccaria pyramidata Species 0.000 abstract 1
- 235000010587 Vaccaria pyramidata Nutrition 0.000 abstract 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 abstract 1
- 239000009136 dragon's blood Substances 0.000 abstract 1
- 206010020718 hyperplasia Diseases 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 235000019509 white turmeric Nutrition 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 description 13
- 201000010099 disease Diseases 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 208000002193 Pain Diseases 0.000 description 12
- 238000002604 ultrasonography Methods 0.000 description 11
- 235000021251 pulses Nutrition 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 230000003203 everyday effect Effects 0.000 description 8
- 208000029312 Muscular tumor Diseases 0.000 description 7
- 210000001672 ovary Anatomy 0.000 description 7
- 241000407170 Curcuma Species 0.000 description 5
- 208000007106 menorrhagia Diseases 0.000 description 5
- 238000005096 rolling process Methods 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- 230000005856 abnormality Effects 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 210000001835 viscera Anatomy 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 230000003821 menstrual periods Effects 0.000 description 3
- 230000027758 ovulation cycle Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 206010000084 Abdominal pain lower Diseases 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010061535 Ovarian neoplasm Diseases 0.000 description 2
- 206010046798 Uterine leiomyoma Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 210000003679 cervix uteri Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 241000521257 Hydrops Species 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010034238 Pelvic adhesions Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000010410 dusting Methods 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000008361 herbal raw material Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000004999 sex organ Anatomy 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 238000009804 total hysterectomy Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a novel traditional Chinese medicinal composition for treating ovarian cyst and a preparation method thereof. The traditional Chinese medicinal composition mainly comprises the following raw material medicines: pangolin scales, tribulus terrestris, spina gleditsiae, rhizoma sparganii, zedoary, leech, ground beeltle, aspongopus, dragon's blood, Chinese trumpet creeper, cowherb seed, suberect spatholobus stem, twotooth achyranthes root, motherwort herb, peach kernel, red flower, szechuan lovage rhizome, immature bitter orange, szechwan chinaberry fruit, pseudoginseng root, cyperus rotundus, Chinese eaglewood and the like. The traditional Chinese medicinal composition can be prepared into any common oral preparation according to the conventional traditional Chinese medicinal preparation method, can obviously improve abnormal menstruation caused by myoma of uterus, colporrhagia, increased leucorrhea, abdomen bilge pendant, abdominal pain, frequent micturition and urination disorder due to myoma pressure on the bladder, constipation and impeded defecating due to myoma pressure on the rectum and other symptoms, and has the advantages of obvious inhibition of cyst hyperplasia, prevention of cancerization, exact clinical curative effect, obvious curative effect, quick response, low cost, fundamentally no toxic or side effect, and the like.
Description
?
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of ovarian cyst.Relating in particular to a kind of is the Chinese medicine composition and preparation method thereof of the treatment ovarian cyst of crude drug with the Chinese herbal medicine.
Background technology
Ovarian cyst belongs to a kind of of sensu lato ovarian tumor, and the various ages all can be ill, but sees so that the women in 20-50 year more.Ovarian tumor is the female sex organs kinds of tumor, the title of " gynecological's first tumor " is arranged,, can be divided into: unitary type or mixed type, a side or bilateral, capsule or substance, optimum or pernicious because of various character and form, see with capsule that wherein the degree that cancerates is very high more.Because the ill phase is seldom ill, so the early diagnosis difficulty, 70% has belonged to late period during prescription on individual diagnosis, seldom can obtain the early treatment, and survival rate was paced up and down all the time at 20-30% in 5 years, is to threaten one of the most serious malignant tumor of women's life.In recent years the clinical onset rate has the trend of continuous rising.The modal clinical manifestation of hysteromyoma is:
Change in menstrual cycle characteristics: menoxenia, menorrhagia, menostaxis, irregular vagina bleeding etc. can appear in muscular tumor patient's common sympton.
Abdominal mass: the conscious abdominal circumference of patient increases, and contacts the lower abdomen enclosed mass.
Leucorrhea abnormal: leucorrhoea grow in quantity can be sanguinopurulent, with stink.
Soreness of waist stomachache: aching pain in waist and back is arranged, and lower abdomen weighs down symptom such as expand, and the muscular tumor base of a fruit twists or muscular tumor red degeneration etc., tormina can occur.
Pressure symptom: because of muscular tumor compressing bladder can cause frequent micturition, dysuria, symptoms such as constipation, stool be not smooth can appear in the compressing rectum.
Clinical proof: a lot of hysteromyoma are in early days without any symptom, and just idol is found when ultrasound diagnosis.
Modern medicine is at clinical a certain symptom treatment, often fall flat, can not find suitable Therapeutic Method, in order to overcome above-mentioned defective, the present invention is based on the differential diagnosis of diseases and the dialectical principle that combines of Chinese traditional treatment ovarian cyst, treating both the principal and secondary aspects of a disease, deficiency and excess is also controlled, inside and outside logical accent, emergency is taken in concurrently, filter out the natural plant of regulating qi-flowing for activating stagnancy, activating blood circulation and dissipating phlegm, blood stasis-eliminating and stagnation-dissipating, softening hardness and disperse swelling,, be prepared from according to certain weight proportion according to the theory of Chinese medical science prescription.A kind of Chinese medicine composition of evident in efficacy, with low cost, treatment ovarian cyst that toxic and side effects is minimum is provided.
Above-mentioned Chinese medicine composition of the present invention adds various conventional adjuvant required when preparing different dosage forms, for example disintegrating agent, lubricant, adhesive etc. are prepared into any oral formulations commonly used with the method for Chinese medicinal of routine, for example can be: pill, capsule, tablet, powder, granule or oral liquid etc.
?
Summary of the invention
Technical problem to be solved by this invention is assorted to overcome above-described shortcoming, and a kind of Chinese medicine composition of treatment ovarian cyst of evident in efficacy, with low cost, almost non-toxic side effect is provided.
Technical problem to be solved by this invention realizes by following technological approaches.
A kind of Chinese medicine composition for the treatment of ovarian cyst of the present invention, the component of main following weight portion is formed:
1～120 part of Squama Manis, 1～100 part of Fructus Tribuli (roasting is ground into powder), Spina Gleditsiae 1～100(roasting is ground into powder) part, 1～100 part of rhizoma sparganic, 1～100 part of Rhizoma Curcumae, 1～50 part of Hirudo (baked coke is ground into powder), 1～50 part of Eupolyphaga Seu Steleophaga, 1～50 part of Aspongopus, 1～30 part of Sanguis Draxonis, 1～100 part of Flos Campsis, 1～120 part of Semen Vaccariae, 1～120 part of Caulis Spatholobi, 1～100 part of Radix Achyranthis Bidentatae, 1～100 part of Herba Leonuri, 1～50 part in Semen Persicae, 1～50 part on Flos Carthami, 1～100 part of Radix Salviae Miltiorrhizae, 1～50 part of Olibanum (processed), 1～50 part of Myrrha (processed), 1～120 part in Rhizoma Curcumae Longae, 1～100 part of Radix Curcumae, 1～120 part of Rhizoma Chuanxiong, 1～120 part of Fructus Aurantii Immaturus, 1～150 part of Fructus Toosendan, 1～100 part of Typhonium flagelliforme (Lodd.) Blume, 1～100 part in Radix Rubiae, 1～100 part of Pericarpium Arecae, 1～120 part of Radix Aristolochiae, 1～120 part of the Radix Linderae, 1～300 part of Rhizoma Cyperi, 1～100 part of Lignum Aquilariae Resinatum, 1～300 part of Pericarpium Citri Reticulatae, 1～100 part of Ramulus Cinnamomi.
Be preferably:
30 parts of Squama Maniss, 20 parts of Fructus Tribulis (roasting is ground into powder), 20 parts of Spina Gleditsiae (roasting is ground into powder), 20 parts of rhizoma sparganic, 20 parts of Rhizoma Curcumae, 15 parts of Hirudos (baked coke is ground into powder), 15 parts of Eupolyphaga Seu Steleophagas, 15 parts of Aspongopuss, 10 parts of Sanguis Draxonis, 20 parts of Flos Campsiss, 30 parts of Semen Vaccariae, 20 parts of Caulis Spatholobis, 20 parts of Radix Achyranthis Bidentataes, 20 parts of Herba Leonuris, 15 parts in Semen Persicae, 15 parts on Flos Carthami, 20 parts of Radix Salviae Miltiorrhizaes, 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 30 parts in Rhizoma Curcumae Longae, 20 parts of Radix Curcumaes, 30 parts of Rhizoma Chuanxiongs, 30 parts of Fructus Aurantii Immaturuss, 50 parts of Fructus Toosendans, 30 parts of Typhonium flagelliforme (Lodd.) Blume, 20 parts in Radix Rubiae, 20 parts of Pericarpium Arecae, 30 parts of Radix Aristolochiaes, 30 parts of the Radixs Linderae, 100 parts of Rhizoma Cyperi, 20 parts of Lignum Aquilariae Resinatum, 150 parts of Pericarpium Citri Reticulataes, 20 parts of Ramulus Cinnamomi.
The weight portion consumption of each component of Chinese medicine composition of the present invention can also be:
1～120 part of Herba Lysimachiae, 1～100 part of Cortex Periplocae, 1～150 part of Semen Coicis, 1～150 part in Poria, 1～100 part of Cortex Magnoliae Officinalis, 1～100 part of Rhizoma Atractylodis, 1～50 part of Fructus Amomi, 1～100 part of Cortex Lycii, 1～100 part of Radix Et Rhizoma Rhei, 1～100 part of Radix Sophorae Flavescentis, 1～100 part of Radix Paeoniae Rubra, 1～120 part of the Radix Paeoniae Alba, 1～100 part of Cortex Moutan, 1～120 part of Flos Lonicerae, 1～100 part of Herba Violae, 1～50 part of Fructus Forsythiae, 1～120 part of Radix Angelicae Sinensis.
Be preferably:
30 parts of Herba Lysimachiaes, 30 parts of Cortex Periplocaes, 100 parts of Semen Coiciss, 50 parts in Poria, 20 parts of Cortex Magnoliae Officinalis, 20 parts of Rhizoma Atractylodis, 15 parts of Fructus Amomis, 20 parts of Cortex Lycii, 20 parts of Radix Et Rhizoma Rhei, 20 parts of Radix Sophorae Flavescentiss, 20 parts of Radix Paeoniae Rubra, 30 parts of the Radix Paeoniae Albas, 30 parts of Cortex Moutans, 30 parts of Flos Loniceraes, 20 parts of Herba Violaes, 15 parts of Fructus Forsythiaes, 30 parts of Radix Angelicae Sinensis.
Above-mentioned Chinese medicine composition of the present invention adds various conventional adjuvant required when preparing different dosage form, for example disintegrating agent, lubricant, adhesive etc. are prepared into any oral formulations commonly used with the method for Chinese medicinal of routine, for example can be pill, capsule, tablet, powder, granule or oral liquid etc.
Chinese medicine composition of the present invention is opened one's minds based on traditional Chinese medical science the five internal organs differentiation of syndromes of YIN and YANG guiding principle, in conjunction with safe one and Pu innovation theory system " ten thousand diseases ascent theory ", " the five internal organs differentiation of syndromes of YIN and YANG guiding principle ", " three-dimensional conservation regulation and control rule " and clinical treatment " pairing principle " are as instructing, take place in conjunction with disease, development and the rule that changes, classify according to the original new drug system, formation is monarch with " the five internal organs basic function is adjusted; equilibrium between yin and yang coordination side ", " the main pathogenesis of the five internal organs adjustment side " is minister, " therapy of serious disease side " is assistant, " clinical fundamental symptoms symptomatic treatment side " Chinese medicine patent medicine " original new drug system " for making.
The used herbal raw material medicine of the present invention all can be buied from the Chinese medicine shop, and its specification meets national medical standard.
Usage and dosage: dosage of the present invention depends on concrete dosage form, factors such as patient age, body weight, health status.As guidance: for oral administration: 1) capsule: obey 2～5 every day three times at every turn, every content of dispersion 0.4 gram, warm water takes.2) tablet: every day three times, each 2～4, every content of dispersion 0.5 gram, warm water takes.3) pill: every day three times, each 5 grams, warm water takes.4) granule: every day three times.Each 5 grams, warm water takes.
The treatment that the present invention is directed to the ovarian cyst patient is very effective, various crude drug are coordinated mutually can play together and are at utmost brought into play drug effect, can effectively improve the self-coordination ability of patient's body, significantly improve function and clinical subjective symptoms, have advantage such as have no side effect, expense is lower in addition.
The specific embodiment
Further describe the present invention by the following examples, it should be understood that these embodiment only are used for the purpose of illustration, never are limited to the present invention.
The preparation of [embodiment 1] capsule
Take by weighing each raw material by following weight portion: 30 parts of Squama Maniss, 20 parts of Fructus Tribulis (roasting is ground into powder), 20 parts of Spina Gleditsiae (roasting is ground into powder), 20 parts of rhizoma sparganic, 20 parts of Rhizoma Curcumae, 15 parts of Hirudos (baked coke is ground into powder), 15 parts of Eupolyphaga Seu Steleophagas, 15 parts of Aspongopuss, 10 parts of Sanguis Draxonis, 20 parts of Flos Campsiss, 30 parts of Semen Vaccariae, 20 parts of Caulis Spatholobis, 20 parts of Radix Achyranthis Bidentataes, 20 parts of Herba Leonuris, 15 parts in Semen Persicae, 15 parts on Flos Carthami, 20 parts of Radix Salviae Miltiorrhizaes, 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 30 parts in Rhizoma Curcumae Longae, 20 parts of Radix Curcumaes, 30 parts of Rhizoma Chuanxiongs, 30 parts of Fructus Aurantii Immaturuss, 50 parts of Fructus Toosendans, 30 parts of Typhonium flagelliforme (Lodd.) Blume, 20 parts in Radix Rubiae, 20 parts of Pericarpium Arecae, 30 parts of Radix Aristolochiaes, 30 parts of the Radixs Linderae, 100 parts of Rhizoma Cyperi, 20 parts of Lignum Aquilariae Resinatum, 150 parts of Pericarpium Citri Reticulataes, 20 parts of Ramulus Cinnamomi.
Grind into after each component mixing with above-mentioned weight and incapsulate promptly after fine powder is crossed 1500 mesh sieves.
The preparation of [embodiment 2] granule
Take by weighing each raw material by following weight portion: 30 parts of Squama Maniss, 20 parts of Fructus Tribulis (roasting is ground into powder), 20 parts of Spina Gleditsiae (roasting is ground into powder), 20 parts of rhizoma sparganic, 20 parts of Rhizoma Curcumae, 15 parts of Hirudos (baked coke is ground into powder), 15 parts of Eupolyphaga Seu Steleophagas, 15 parts of Aspongopuss, 10 parts of Sanguis Draxonis, 20 parts of Flos Campsiss, 30 parts of Semen Vaccariae, 20 parts of Caulis Spatholobis, 20 parts of Radix Achyranthis Bidentataes, 20 parts of Herba Leonuris, 15 parts in Semen Persicae, 15 parts on Flos Carthami, 20 parts of Radix Salviae Miltiorrhizaes, 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 30 parts in Rhizoma Curcumae Longae, 20 parts of Radix Curcumaes, 30 parts of Rhizoma Chuanxiongs, 30 parts of Fructus Aurantii Immaturuss, 50 parts of Fructus Toosendans, 30 parts of Typhonium flagelliforme (Lodd.) Blume, 20 parts in Radix Rubiae, 20 parts of Pericarpium Arecae, 30 parts of Radix Aristolochiaes, 30 parts of the Radixs Linderae, 100 parts of Rhizoma Cyperi, 20 parts of Lignum Aquilariae Resinatum, 150 parts of Pericarpium Citri Reticulataes, 20 parts of Ramulus Cinnamomi.
Each raw material of above-mentioned weight fraction is mixed, after grinding into fine powder and crossing 1500 mesh sieves, add ethanol and make adhesive, add starch and do filler, be pressed into granule.
The preparation of [embodiment 3] tablet
Take by weighing each raw material by following weight portion: 30 parts of Squama Maniss, 20 parts of Fructus Tribulis (roasting is ground into powder), 20 parts of Spina Gleditsiae (roasting is ground into powder), 20 parts of rhizoma sparganic, 20 parts of Rhizoma Curcumae, 15 parts of Hirudos (baked coke is ground into powder), 15 parts of Eupolyphaga Seu Steleophagas, 15 parts of Aspongopuss, 10 parts of Sanguis Draxonis, 20 parts of Flos Campsiss, 30 parts of Semen Vaccariae, 20 parts of Caulis Spatholobis, 20 parts of Radix Achyranthis Bidentataes, 20 parts of Herba Leonuris, 15 parts in Semen Persicae, 15 parts on Flos Carthami, 20 parts of Radix Salviae Miltiorrhizaes, 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 30 parts in Rhizoma Curcumae Longae, 20 parts of Radix Curcumaes, 30 parts of Rhizoma Chuanxiongs, 30 parts of Fructus Aurantii Immaturuss, 50 parts of Fructus Toosendans, 30 parts of Typhonium flagelliforme (Lodd.) Blume, 20 parts in Radix Rubiae, 20 parts of Pericarpium Arecae, 30 parts of Radix Aristolochiaes, 30 parts of the Radixs Linderae, 100 parts of Rhizoma Cyperi, 20 parts of Lignum Aquilariae Resinatum, 150 parts of Pericarpium Citri Reticulataes, 20 parts of Ramulus Cinnamomi.
Each raw material of above-mentioned weight portion is mixed, after grinding into fine powder and crossing 800～1200 order dusting covers, make tablet promptly.
The preparation of [embodiment 4] pill
Take by weighing each raw material by following weight portion: 30 parts of Squama Maniss, 20 parts of Fructus Tribulis (roasting is ground into powder), 20 parts of Spina Gleditsiae (roasting is ground into powder), 20 parts of rhizoma sparganic, 20 parts of Rhizoma Curcumae, 15 parts of Hirudos (baked coke is ground into powder), 15 parts of Eupolyphaga Seu Steleophagas, 15 parts of Aspongopuss, 10 parts of Sanguis Draxonis, 20 parts of Flos Campsiss, 30 parts of Semen Vaccariae, 20 parts of Caulis Spatholobis, 20 parts of Radix Achyranthis Bidentataes, 20 parts of Herba Leonuris, 15 parts in Semen Persicae, 15 parts on Flos Carthami, 20 parts of Radix Salviae Miltiorrhizaes, 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 30 parts in Rhizoma Curcumae Longae, 20 parts of Radix Curcumaes, 30 parts of Rhizoma Chuanxiongs, 30 parts of Fructus Aurantii Immaturuss, 50 parts of Fructus Toosendans, 30 parts of Typhonium flagelliforme (Lodd.) Blume, 20 parts in Radix Rubiae, 20 parts of Pericarpium Arecae, 30 parts of Radix Aristolochiaes, 30 parts of the Radixs Linderae, 100 parts of Rhizoma Cyperi, 20 parts of Lignum Aquilariae Resinatum, 150 parts of Pericarpium Citri Reticulataes, 20 parts of Ramulus Cinnamomi.
Each raw material of above-mentioned weight is mixed, grind into cross 600～1000 mesh sieves behind the fine powder after, make pill promptly.
The preparation of [embodiment 5] oral liquid
Take by weighing each raw material by following weight portion:
Each raw material of above-mentioned weight is mixed, after three decoctions, three filtrates are mixed, filter, be concentrated into
Normal concentration, put cold, the stock solution embedding, irradiation sterilization, after the check, packed products is made oral liquid promptly.
[experimental example] traditional Chinese medicine composition for treating ovarian cyst of the present invention patient's clinical observation on the therapeutic effect experiment
One, the physical data of experimental subject: adopt Chinese medicine composition of the present invention to treat 39 routine patients altogether, wherein male 0 example, women 39 examples; The oldest person 51 years old, the age reckling has only 20 years old.
Two, Therapeutic Method:
Usage and dosage: adopt the prepared medicament of the embodiment of the invention, its usage and consumption are as follows: 1) capsule: obey 2～5 every day three times at every turn, and every content of dispersion 0.4 gram, warm water takes.2) tablet: every day three times, each 2～4, every content of dispersion 0.5 gram, warm water takes.3) pill: every day three times, each 5 grams, warm water takes.4) granule: every day three times.Each 5 grams, warm water takes.
The course of treatment: one month is a course of treatment, treats for 5 courses of treatment altogether.
Three, therapeutic evaluation standard
Cure: sign and symptom are improved fully, and be happy, in high spirits.
Produce effects: sign and symptom are significantly improved, and be happy, and spirit is fine.
Effectively: sign and symptom change, and random thoughts have discomfort slightly, but can accept.
Invalid: sign does not have change, symptom such as preceding.
Four, model case:
1, blue so-and-so, woman, 28 years old.
The patient finds ovarian cyst because of pregnant January during artificial abortion, through ultrasound diagnosis, and uterus right ovary cyst, 4.7cm * 6cm * 4cm size, and companion's band polychrome Huang, the flavor raw meat, lower abdomen pain, operation is advised by hospital.Because of the patient does not educate, and fear is nourished in operation, so select traditional Chinese medical science expectant treatment.
Took Chinese medicine composition of the present invention 1 month, patient's leukorrhagia is normal substantially, and stomachache disappears.Continue and obeyed Chinese medicine composition of the present invention 1 month, through ultrasound diagnosis, lump is condensed to 1.3cm * 1.5cm * 0.6cm.Continue and obeyed Chinese medicine composition of the present invention 2 months, B ultrasonic prompting once more, lump disappears.
2, Zhang, woman, 41 years old.
Patient's right ovary cyst, the last October excision, cyst is found in the left side again in succession, 3.2cm * 4.5cm size, non-evident sympton is reluctant to perform an operation, so come to go to a doctor.Tongue is normal, white and thin fur, and the rolling pulse chi is unable.Disease is the long-pending Suo Zhi mass in the abdomen of blood stasis water.
Took Chinese medicine composition of the present invention 10, menstrual onset, amount can, left lower abdomen dull pain, tongue is dark red, white and thin fur, rolling pulse.Continue and obeyed Chinese medicine composition of the present invention 2 months, hospital does ultrasound diagnosis and finds that left ovary has the big cyst of 1.9cm * 1.84cm.Red tongue, white and thin fur, rolling pulse.Continue and obey 1 first quarter moon of Chinese medicine composition of the present invention, ultrasound diagnosis is done by hospital, and ovarian cyst disappears.
3, Zhang, woman, 30 years old.
Patient's private prosecution right ovary cyst 4.9cm * 3.0cm, right lower abdominal pain, menstruation tide 12 the beginning of the year, once do not rise without hormone half a year, and 2-3 month closely more than a year is once.Patient's December was examined on the 3rd, and is heavy through preceding right lower abdominal pain last menstrual period November 24, red tongue, white and thin fur, slippery and rapid pulse.
Took Chinese medicine composition of the present invention 4, its lower abdomen pain relief, red tongue, white and thin fur, rolling pulse.Continue and obeyed Chinese medicine composition of the present invention 20, right few abdomen pain disappears.The clothes Chinese medicine composition of the present invention that continues is surplus February, states it in certain hospital's ultrasound diagnosis, the uterus adnexa no abnormality seen, and ovarian cyst disappears.
4, often so-and-so, woman, 45 years old.
The patient before 3 months no obvious inducement the menstruation menostaxis appears.Previously menstruation 5 days is clean, existing over nearly 3 months menostaxis to 10-15 days.Last menstrual period March 15, not to the utmost dripping, through row 26 days, the light amount of color was held clot less under the arm.Pointed out in hospital's ultrasound diagnosis April 11: " right adnexa capsule enclosed mass 7.8 * 3.2cm, left fallopian tube hydrops, little muscular tumor 1.1 * 0.9 * 1.0cm in uterus." through the fore udder distending pain, leucorrhea amount is many to have abnormal flavour as the bean dregs sample, receive can, just two normal, the peace of sleeping night, red tongue with thin fur is white, deep-thready pulse is puckery.
Took Chinese medicine composition of the present invention 3, menstrual onset, through row 5 days, chromaticness was as usual.Continue and obeyed Chinese medicine composition of the present invention 1 month, all diseases obviously alleviate, and the B ultrasonic prompting: right side Nang Xingbao disappears soon.The clothes Chinese medicine composition of the present invention 2 months that continues, menstrual cycle is normal, generally through row 4-5 days, measures mediumly, and chromaticness is normal; The woman examines prompting: cervix uteri is slightly rotten to the corn; Leukorrhagia is normal.Continue and obeyed Chinese medicine composition of the present invention 1 month, in hospital's ultrasound diagnosis, the uterus adnexa no abnormality seen.
5, the king so-and-so, woman, 39 years old.
Patient's ovarian cyst postoperative recurrence is found right side one week of adnexa enclosed mass, examines in January, 2007.Patient's capable right ovary inner membrance sample cyst decollement in 2002, the pelvic adhesion exclusion.Because of recurrence, capable total hysterectomy+left ovary excision+right ovary inner membrance sample cyst decollement in 2004.Last week, check was found, right side adnexa enclosed mass, and hospital's B ultrasonic shows: right attachment area reality lump, size is 4.6 * 4.0cm.Distention and pain of breast before menstruation, the soreness of waist expands unable, following abdominal distention, sensation of pricking, the leucorrhea amount is many, dizziness and tinnitus, urine urgency-frequency, xerostomia, weak, dull purple tongue, the few Tianjin of thin fur, thready and hesitant pulse.Card belongs to qi depression to blood stasis, interior-heat caused by deficiency of YIN.
Took Chinese medicine composition of the present invention 1 month, leucorrhea reduces, and distention and pain of breast before menstruation alleviates.Continue and obeyed Chinese medicine composition of the present invention 1 month, clinical all diseases are all slow, and leucorrhea is normal, has not had significant discomfort menstrual period; The ultrasound diagnosis prompting, right side attachment area lump transfers mixing to from substance.Continue and obeyed Chinese medicine composition of the present invention 1 month, the patient has not had the disease of any discomfort; The ultrasound diagnosis prompting, ovarian cyst disappears, and quality of life improves greatly, and the mountain-climbing pleasure trip on foot also has not big harm.
6, the week so-and-so, woman, 22 years old.
The patient tells its nearly March, the few abdomen dull pain discomfort of time sense, and few through the row amount, color and luster is purple dark, examines and sees lustreless complexion, and dimly red tongue has purple gas, stringy and rolling pulse.B ultrasonic scanning uterus adnexa shows, anteposition of uterus, and size and form is normal, no abnormality seen in utero, the right side adnexa sees that a diameter is the no echo area of 3.8 * 3.6cm, and the border is clear, and back wall echo strengthens, the left side attachment no abnormality seen.Examine and be ovarian cyst.
Took Chinese medicine composition of the present invention 10, few abdomen dull pain disappears.The clothes Chinese medicine composition of the present invention 2 months that continues, patient's complexion takes a turn for the better, and private prosecution is smooth and easy through row, and is moderate through measuring, color is red; B ultrasonic scanning uterus adnexa, ovarian cyst disappears.
7, Deng, woman, 26 years old.
The patient Ceng You history of repeatedly miscarrying, after cause infertile.3 months serious dysmenorrheas of cause, hospital treatment.Left adnexal cyst 5.5 * 4.3cm is found in the back.After this seek the doctor everywhere, but curative effect is very little.Find after further consultation last month that it is 6.5 * 5.1cm that cyst increases.Excessive because of cyst, the doctor advises it to perform an operation as early as possible.Consider own year side 26 years old, hesitate, always so the diagnosis and treatment of coming.Disease sees that gastral cavilty is full vexed, and nervous breathing hard is off one's feed, menoxenia, and dysuria, it is not smooth to defecate, and lower abdomen weighs down and expands.Be diagnosed as: ovarian cyst.
Took Chinese medicine composition of the present invention 15, full vexed, the nervous remission of breathing hard of patient's gastral cavilty is received and is increased.Continue and obeyed Chinese medicine composition of the present invention 15, all diseases are significantly improved, and two is just smooth and easy, and lower abdomen weighs down the sense of expanding and disappears, and cyst is obviously dwindled.Continue and obeyed Chinese medicine composition of the present invention 3 months, the patient has not had any discomfort, the menstruation rule; The ultrasound diagnosis prompting, ovarian cyst disappears.
8, Liu, woman, 43 years old.
The patient is surplus unclean May because of menostaxis, and checks that to hospital B ultrasonic shows: cervical hypertrophy, in utero little muscular tumor, right side adnexal cyst.Disease is seen dizzy weak, lusterless complexion, often breast is coerced vexed bloated burning pain, receive food still can, two is just normal, thin white fur of tongue, deep-thready pulse.
Took Chinese medicine composition of the present invention 1 month, in utero little muscular tumor disappears, and cyst is obviously dwindled.Continue and obeyed Chinese medicine composition of the present invention 1 month, menstrual cycle recovers normally substantially, and distending pain in the chest and hypochondrium removes.Continue and obeyed Chinese medicine composition of the present invention 1 month, all diseases are removed, and menstruation recovery is normal, have rosy cheeks, and head is not dizzy; The B ultrasonic check: body of uterus has recovered normal size, and cervix uteri is not plump, and the right side adnexal cyst disappears.
Five, therapeutic outcome:
In the 39 routine cases of being accepted for medical treatment,, wherein cure 11 examples through treatment in 5 months, produce effects 14 examples, effective 8 examples, invalid 6 examples, total effective rate reaches 85%.The result shows that Chinese medicine composition of the present invention has extremely significant curative effect to treatment ovarian cyst patient.
Claims (7)
1. Chinese medicine composition for the treatment of ovarian cyst is characterized in that: mainly contain following bulk drugs and form:
1～120 part of Squama Manis, 1～100 part of Fructus Tribuli (roasting is ground into powder), Spina Gleditsiae 1～100(roasting is ground into powder) part, 1～100 part of rhizoma sparganic, 1～100 part of Rhizoma Curcumae, 1～50 part of Hirudo (baked coke is ground into powder), 1～50 part of Eupolyphaga Seu Steleophaga, 1～50 part of Aspongopus, 1～30 part of Sanguis Draxonis, 1～100 part of Flos Campsis, 1～120 part of Semen Vaccariae, 1～120 part of Caulis Spatholobi, 1～100 part of Radix Achyranthis Bidentatae, 1～100 part of Herba Leonuri, 1～50 part in Semen Persicae, 1～50 part on Flos Carthami, 1～100 part of Radix Salviae Miltiorrhizae, 1～50 part of Olibanum (processed), 1～50 part of Myrrha (processed), 1～120 part in Rhizoma Curcumae Longae, 1～100 part of Radix Curcumae, 1～120 part of Rhizoma Chuanxiong, 1～120 part of Fructus Aurantii Immaturus, 1～150 part of Fructus Toosendan, 1～100 part of Typhonium flagelliforme (Lodd.) Blume, 1～100 part in Radix Rubiae, 1～100 part of Pericarpium Arecae, 1～120 part of Radix Aristolochiae, 1～120 part of the Radix Linderae, 1～300 part of Rhizoma Cyperi, 1～100 part of Lignum Aquilariae Resinatum, 1～300 part of Pericarpium Citri Reticulatae, 1～100 part of Ramulus Cinnamomi.
2. according to the described Chinese medicine composition of claim 1, it is characterized in that: the weight portion of each crude drug is:
30 parts of Squama Maniss, 20 parts of Fructus Tribulis (roasting is ground into powder), 20 parts of Spina Gleditsiae (roasting is ground into powder), 20 parts of rhizoma sparganic, 20 parts of Rhizoma Curcumae, 15 parts of Hirudos (baked coke is ground into powder), 15 parts of Eupolyphaga Seu Steleophagas, 15 parts of Aspongopuss, 10 parts of Sanguis Draxonis, 20 parts of Flos Campsiss, 30 parts of Semen Vaccariae, 20 parts of Caulis Spatholobis, 20 parts of Radix Achyranthis Bidentataes, 20 parts of Herba Leonuris, 15 parts in Semen Persicae, 15 parts on Flos Carthami, 20 parts of Radix Salviae Miltiorrhizaes, 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 30 parts in Rhizoma Curcumae Longae, 20 parts of Radix Curcumaes, 30 parts of Rhizoma Chuanxiongs, 30 parts of Fructus Aurantii Immaturuss, 50 parts of Fructus Toosendans, 30 parts of Typhonium flagelliforme (Lodd.) Blume, 20 parts in Radix Rubiae, 20 parts of Pericarpium Arecae, 30 parts of Radix Aristolochiaes, 30 parts of the Radixs Linderae, 100 parts of Rhizoma Cyperi, 20 parts of Lignum Aquilariae Resinatum, 150 parts of Pericarpium Citri Reticulataes, 20 parts of Ramulus Cinnamomi.
3. according to the described Chinese medicine composition of claim 1, wherein crude drug also has:
1～120 part of Herba Lysimachiae, 1～100 part of Cortex Periplocae, 1～150 part of Semen Coicis, 1～150 part in Poria, 1～100 part of Cortex Magnoliae Officinalis, 1～100 part of Rhizoma Atractylodis, 1～50 part of Fructus Amomi, 1～100 part of Cortex Lycii, 1～100 part of Radix Et Rhizoma Rhei, 1～100 part of Radix Sophorae Flavescentis, 1～100 part of Radix Paeoniae Rubra, 1～120 part of the Radix Paeoniae Alba, 1～100 part of Cortex Moutan, 1～120 part of Flos Lonicerae, 1～100 part of Herba Violae, 1～50 part of Fructus Forsythiae, 1～120 part of Radix Angelicae Sinensis.
4. according to the described Chinese medicine composition of claim 3, wherein the weight portion of each component is:
30 parts of Herba Lysimachiaes, 30 parts of Cortex Periplocaes, 100 parts of Semen Coiciss, 50 parts in Poria, 20 parts of Cortex Magnoliae Officinalis, 20 parts of Rhizoma Atractylodis, 15 parts of Fructus Amomis, 20 parts of Cortex Lycii, 20 parts of Radix Et Rhizoma Rhei, 20 parts of Radix Sophorae Flavescentiss, 20 parts of Radix Paeoniae Rubra, 30 parts of the Radix Paeoniae Albas, 30 parts of Cortex Moutans, 30 parts of Flos Loniceraes, 20 parts of Herba Violaes, 15 parts of Fructus Forsythiaes, 30 parts of Radix Angelicae Sinensis.
5. according to claim 1,2,3 or 4 described any Chinese medicine compositions, it is characterized in that: can be prepared into any oral formulations commonly used according to the method for Chinese medicinal of routine.
6. according to the described Chinese medicine composition of claim 5, it is characterized in that: described oral formulations is pill, capsule, tablet, powder, granule or oral liquid.
7. the application of the described any Chinese medicine composition of claim 1～6 in preparation treatment ovarian cyst medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102250802A CN101966322A (en) | 2010-07-13 | 2010-07-13 | Traditional Chinese medicinal composition for treating ovarian cyst and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102250802A CN101966322A (en) | 2010-07-13 | 2010-07-13 | Traditional Chinese medicinal composition for treating ovarian cyst and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101966322A true CN101966322A (en) | 2011-02-09 |
Family
ID=43545584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010102250802A Pending CN101966322A (en) | 2010-07-13 | 2010-07-13 | Traditional Chinese medicinal composition for treating ovarian cyst and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101966322A (en) |
Cited By (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102302733A (en) * | 2011-08-29 | 2012-01-04 | 刘金彪 | Oral Chinese medicinal composition for treating ovarian cyst |
| CN102302594A (en) * | 2011-09-14 | 2012-01-04 | 山东中医药大学 | Drug-separated navel moxibustion traditional Chinese drug composition for treating hysteromyoma |
| CN102406875A (en) * | 2011-11-21 | 2012-04-11 | 李光彩 | Medicine for treating endometriosis interna |
| CN102580050A (en) * | 2012-03-27 | 2012-07-18 | 房学锋 | Externally applied traditional Chinese medicine combination for treating chronic pelvic inflammatory disease through applying iontophoresis and preparation method |
| CN102631645A (en) * | 2012-05-09 | 2012-08-15 | 张静 | Medicine for treating hyperplasia of mammary glands and ovarian cyst |
| CN102973677A (en) * | 2012-12-25 | 2013-03-20 | 刘红伟 | Traditional Chinese medicine for treating ovarian cyst |
| CN103100011A (en) * | 2011-11-11 | 2013-05-15 | 罗楚洪 | Traditional Chinese medicinal composition and traditional Chinese medicinal preparation for treating gynecological diseases |
| CN103494985A (en) * | 2013-10-11 | 2014-01-08 | 刘正菊 | Externally applied patch for treating gynecological myoma of uterus and ovarian cyst |
| CN103520571A (en) * | 2013-10-18 | 2014-01-22 | 潘健 | Traditional Chinese medicine for treating qi stagnation and blood stasis syndrome type abdominal mass diseases |
| CN103638385A (en) * | 2013-12-10 | 2014-03-19 | 张朝兰 | Medicine for treating ovarian cyst and preparation method of medicine |
| CN104173508A (en) * | 2014-08-19 | 2014-12-03 | 四川金堂海纳生物医药技术研究所 | Medicine for treating ovarian cyst and preparation method of medicine |
| CN104338083A (en) * | 2014-11-04 | 2015-02-11 | 薛学明 | Medicament for treating irregular menstruation and preparation method thereof |
| CN104491222A (en) * | 2014-12-16 | 2015-04-08 | 曹明军 | Traditional Chinese medicine for treating bovine follicle cyst and preparation method thereof |
| CN105435023A (en) * | 2015-12-14 | 2016-03-30 | 蓝表芳 | Traditional Chinese medicine composition treating ovarian cyst |
| CN105833230A (en) * | 2016-05-18 | 2016-08-10 | 陆利花 | A kind of Chinese herbal medicine composition for treating ovarian cyst and preparation method thereof |
| CN107469134A (en) * | 2017-08-15 | 2017-12-15 | 深圳菲朗生物科技有限公司 | Protection pad and traditional Chinese medicinal components for the protection pad and preparation method thereof |
| CN115120693A (en) * | 2022-07-25 | 2022-09-30 | 安徽医科大学 | A kind of traditional Chinese medicine compound preparation for treating ovarian cyst and preparation method thereof |
-
2010
- 2010-07-13 CN CN2010102250802A patent/CN101966322A/en active Pending
Cited By (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102302733A (en) * | 2011-08-29 | 2012-01-04 | 刘金彪 | Oral Chinese medicinal composition for treating ovarian cyst |
| CN102302594A (en) * | 2011-09-14 | 2012-01-04 | 山东中医药大学 | Drug-separated navel moxibustion traditional Chinese drug composition for treating hysteromyoma |
| CN102302594B (en) * | 2011-09-14 | 2013-03-27 | 山东中医药大学 | Drug-separated navel moxibustion traditional Chinese drug composition for treating hysteromyoma |
| CN103100011B (en) * | 2011-11-11 | 2014-11-26 | 罗楚洪 | Traditional Chinese medicinal composition and traditional Chinese medicinal preparation for treating gynecological diseases |
| CN103100011A (en) * | 2011-11-11 | 2013-05-15 | 罗楚洪 | Traditional Chinese medicinal composition and traditional Chinese medicinal preparation for treating gynecological diseases |
| CN102406875A (en) * | 2011-11-21 | 2012-04-11 | 李光彩 | Medicine for treating endometriosis interna |
| CN102580050B (en) * | 2012-03-27 | 2013-11-20 | 房学锋 | Externally applied traditional Chinese medicine combination for treating chronic pelvic inflammatory disease through applying iontophoresis and preparation method |
| CN102580050A (en) * | 2012-03-27 | 2012-07-18 | 房学锋 | Externally applied traditional Chinese medicine combination for treating chronic pelvic inflammatory disease through applying iontophoresis and preparation method |
| CN102631645A (en) * | 2012-05-09 | 2012-08-15 | 张静 | Medicine for treating hyperplasia of mammary glands and ovarian cyst |
| CN102631645B (en) * | 2012-05-09 | 2013-11-20 | 张静 | Medicine for treating hyperplasia of mammary glands and ovarian cyst |
| CN102973677A (en) * | 2012-12-25 | 2013-03-20 | 刘红伟 | Traditional Chinese medicine for treating ovarian cyst |
| CN102973677B (en) * | 2012-12-25 | 2014-08-27 | 刘红伟 | Traditional Chinese medicine for treating ovarian cyst |
| CN103494985A (en) * | 2013-10-11 | 2014-01-08 | 刘正菊 | Externally applied patch for treating gynecological myoma of uterus and ovarian cyst |
| CN103494985B (en) * | 2013-10-11 | 2015-07-08 | 刘正菊 | Externally applied patch for treating gynecological myoma of uterus and ovarian cyst |
| CN103520571A (en) * | 2013-10-18 | 2014-01-22 | 潘健 | Traditional Chinese medicine for treating qi stagnation and blood stasis syndrome type abdominal mass diseases |
| CN103520571B (en) * | 2013-10-18 | 2015-04-01 | 青岛市市立医院 | Traditional Chinese medicine for treating qi stagnation and blood stasis syndrome type abdominal mass diseases |
| CN103638385A (en) * | 2013-12-10 | 2014-03-19 | 张朝兰 | Medicine for treating ovarian cyst and preparation method of medicine |
| CN103638385B (en) * | 2013-12-10 | 2015-07-08 | 张朝兰 | Medicine for treating ovarian cyst and preparation method of medicine |
| CN104173508A (en) * | 2014-08-19 | 2014-12-03 | 四川金堂海纳生物医药技术研究所 | Medicine for treating ovarian cyst and preparation method of medicine |
| CN104338083A (en) * | 2014-11-04 | 2015-02-11 | 薛学明 | Medicament for treating irregular menstruation and preparation method thereof |
| CN104491222A (en) * | 2014-12-16 | 2015-04-08 | 曹明军 | Traditional Chinese medicine for treating bovine follicle cyst and preparation method thereof |
| CN104491222B (en) * | 2014-12-16 | 2018-05-04 | 曹明军 | A kind of Chinese medicine for treating ox follicular cyst and preparation method thereof |
| CN105435023A (en) * | 2015-12-14 | 2016-03-30 | 蓝表芳 | Traditional Chinese medicine composition treating ovarian cyst |
| CN105833230A (en) * | 2016-05-18 | 2016-08-10 | 陆利花 | A kind of Chinese herbal medicine composition for treating ovarian cyst and preparation method thereof |
| CN105833230B (en) * | 2016-05-18 | 2019-11-08 | 陆利花 | Chinese herbal medicine composition for treating ovarian cyst and preparation method thereof |
| CN107469134A (en) * | 2017-08-15 | 2017-12-15 | 深圳菲朗生物科技有限公司 | Protection pad and traditional Chinese medicinal components for the protection pad and preparation method thereof |
| CN115120693A (en) * | 2022-07-25 | 2022-09-30 | 安徽医科大学 | A kind of traditional Chinese medicine compound preparation for treating ovarian cyst and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101966322A (en) | Traditional Chinese medicinal composition for treating ovarian cyst and preparation method thereof | |
| CN101766790B (en) | Chinese medicine composite for treating chronic atrophic gastritis and preparation method thereof | |
| CN101780247B (en) | Traditional Chinese medicine composition for treating acute enteritis and preparation method thereof | |
| CN101785844B (en) | Traditional Chinese medicine combination and preparation method thereof for dysentery treatment | |
| CN101869691B (en) | Chinese medicinal composition for treating dysmenorrhea and preparation method thereof | |
| CN101785850B (en) | Traditional Chinese medicine composition for treating intestinal obstruction and preparation method thereof | |
| CN101816742A (en) | Chinese medicinal composition for treating hemorrhoids and preparation method thereof | |
| CN101757567B (en) | Traditional Chinese medicine composition for treating rectal cancer and preparation method thereof | |
| CN101816776B (en) | Chinese medicinal composition for treating delayed menstrual cycle delayed menstrual cycledelayed menstrual cycle and preparation method thereof | |
| CN101757566A (en) | Traditional Chinese medicine composition for treating colon cancer and preparation method thereof | |
| CN101966313A (en) | Chinese medicinal composition for treating female infertility and preparation method thereof | |
| CN101785847A (en) | Traditional Chinese medicine combination for intestinal caner treatment and preparation method thereof | |
| CN101966320A (en) | Chinese medicinal composition for treating proliferation of mammary gland and preparation method thereof | |
| CN101966301A (en) | Chinese medicinal composition for treating pelvic inflammation and preparation method thereof | |
| CN101816758B (en) | Traditional Chinese medicine composition for treating preceded menstrual cycle and preparation method thereof | |
| CN103585378B (en) | A Chinese medicinal composition for treating female infertility, and its preparation method | |
| CN101780254B (en) | Traditional Chinese medicine compound for treating intestinal tumor | |
| CN101972445A (en) | Traditional Chinese medicinal composition for treating myoma of uterus and preparation method thereof | |
| CN101757509A (en) | Traditional Chinese medicine composition for treating icterohepatitis and preparation method thereof | |
| CN101961480A (en) | Traditional Chinese medicinal composition for treating hematochezia and preparation method thereof | |
| CN101810835A (en) | Chinese medicinal composition for treating purpura and preparation method thereof | |
| CN101966321A (en) | Traditional Chinese medicinal composition for treating breast cancer and preparation method thereof | |
| CN101966318A (en) | Traditional Chinese medicinal composition for curing breast pain during menstruation and preparation method thereof | |
| CN101773649B (en) | Chinese medicine composition for treating acute abdomen and preparation method thereof | |
| CN101810823B (en) | Chinese medicinal composition for treating renal cyst diseases and use of preparing medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110209 |
|
| WD01 | Invention patent application deemed withdrawn after publication |